Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ReShape Lifesciences Inc. (OBLN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income  -3.5-2.7-11.8-9.4-8.1-35.5-17.7-3.9
Depreciation and amortization   [+]0.00.00.50.50.60.60.50.5
Asset impairment charges  0.10.013.90.10.1 0.10.0
Stock-based compensation  0.20.20.40.80.72.310.7-0.4
Deferred taxes   0.0-0.4  -0.1  
Change in working capital   [+]-3.10.1-1.01.6-0.60.6-4.31.3
Other operating activities  -0.4-2.8-6.90.10.028.72.80.3
Cash from operations  -6.7-5.1-5.3-6.4-7.4-3.4-7.8-2.2
   
Capital expenditures   [+]0.00.00.00.00.0-0.1-0.1-0.1
Acquisitions       -3.0 25.4
Other cash from investing         -20.1
Cash from investing  0.00.00.00.00.0-3.1-0.15.1
   
Issuance of common stock, net  2.310.2      
Option exercises        0.20.2
Financing costs        -3.2 
Other cash from financing    0.02.5  -6.135.5
Cash from financing  2.310.20.02.50.00.0-3.035.3
   
Free cash flow  -6.7-5.1-5.3-6.4-7.4-3.5-7.9-2.3
        Per share (diluted)  ($2.06)($2.97)($0.24)($16.66)($19.90)($0.28)($0.46)($0.50)
   
Cash paid for interest         0.3
Cash paid for income taxes       0.10.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy